Condition
Stereotactic Body Radiotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Stereotactic Body Radiotherapy clinical trials that are recruiting, at sites in 5 countries (most in China (2), Italy (1), South Korea (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Stereotactic Body Radiotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Functional Lung-Sparing Planning Guided by Lung Perfusion PET/CT vs. Anatomy for Lung SBRT | Phase 3 | Brest, Finistère and 1 other locations | Recruiting | Dec 17, 2025 |
| Stereotactic Body Radiotherapy with Continuous Tracking for Kidney Tumors | — | Milan, Milano (MI) | Recruiting | Dec 16, 2025 |
| Comparing adaptive SBRT to standard image-guided SBRT for localized prostate cancer | Phase 3 | Toronto, Ontario | Recruiting | Feb 13, 2025 |
| Using preoperative radiotherapy and surgery for treating soft tissue sarcoma in limbs | — | Hangzhou, Zhejiang | Recruiting | Jan 6, 2025 |
| Combining atezolizumab and bevacizumab with stereotactic body radiotherapy for advanced liver cancer | — | Yongin-si | Recruiting | Sep 19, 2024 |
| Eliminating PTV Margins in Lung Cancer Treatment | Phase 2 | Guangzhou, Guangdong | Recruiting | Aug 7, 2024 |
All recruiting trials (6)
-
Functional Lung-Sparing Planning Guided by Lung Perfusion PET/CT vs. Anatomy for Lung SBRT
We test whether planning lung SBRT with functional lung information from a PET/CT scan can spare healthy lung tissue and reduce side effects for adult patients with primary or metastatic lung tumors.
-
Stereotactic Body Radiotherapy with Continuous Tracking for Kidney Tumors
This trial tests a precise, high-dose SBRT approach to treat primary or secondary kidney tumors in adults using robotic tracking to see if it reduces kidney and treatment-related side effects.
-
Comparing adaptive SBRT to standard image-guided SBRT for localized prostate cancer
This study is testing if a new type of targeted radiation therapy for prostate cancer can improve urinary health compared to the standard radiation treatment.
-
Using preoperative radiotherapy and surgery for treating soft tissue sarcoma in limbs
This study is testing if giving radiation therapy before surgery can help people with large or difficult-to-remove soft tissue tumors in their arms or legs feel better and have better outcomes.
-
Combining atezolizumab and bevacizumab with stereotactic body radiotherapy for advanced liver cancer
This study is testing if combining two cancer drugs with a specific type of radiation therapy can help people with advanced liver cancer feel better and improve their treatment outcomes.
-
Eliminating PTV Margins in Lung Cancer Treatment
This study is testing if removing certain safety margins during a specific type of lung cancer radiation treatment can help patients feel better and have fewer side effects compared to the standard method.
Related topics
Quick answers
How many Stereotactic Body Radiotherapy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (2 trials), Italy (1 trial), South Korea (1 trial), Canada (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.